Idlir Liçaj, PhD
Biostatistitian

In 2007, I obtained the Master of Science (MSc) from the University Paris XI, France and in 2011 the PhD in epidemiology and statistics from the University of Lyon, France. In addition to my positions as lead statistician in clinical trials projects for different global pharmaceutical institutions such as Astrazeneca, and Novo Nordisk, I am a part time scientist from the Arctic University of Norway.

This allows me to keep continuous exposure to academic research and scientific publications in cancer research. I have conceptualised and executed the analyses of several high ranking peer review publications.

I supervise junior statisticians and methodological aspects of PhD students at the Arctic University of Norway, Tromso Norway and the Cancer Comprehensive Center F. Baclesse, Caen, France.
Idlir Licaj
My Experience
Biostatistician with extensive experience in research and industry. Particular expertise in statistical inference, protocol development, sample size estimation, mix models, survival analysis, and multiple imputation.

I have co-authored more than 70 peer-reviewed publications mainly in the area of cancer research. Therapeutic areas of experience include: oncology, respiratory and rare diseases. I have acquired advanced statistical programming skills in SAS, R and Stata.
  • CRO Kappa Santé – Paris France
  • International Agency for Research on Cancer - Lyon, France
  • UiT The Artic University of Norway - Tromso, Norway
  • Cancer Comprehensive Center Baclesse - Caen, France
  • Cytel - Spain, SL
  • Novo Nordisk - Madrid Spain

My education

University Claude Bernard Lyon 1 –UCBL. France
PhD Biostatistics and Epidemiology (2007-2011)

University Paris XI, Paris France
Master of Science (MSc) Public Health & Statistics (2006-2007)

University Paris V “R. Descartes”, France. Licence1-Licence3 
 Applied mathematics in social sciences (MASS) (2002-2006)